StockMacro
Company, fund or insider

Help

Menu

Inogen

$5.30 -19% in 6 monthsMarket cap $137.8M

INGN on XNAS, Health Care, Inogen Inc, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue fell 16% to $77.2M and the stock is down 20% in a year.

  • BadNet loss of $35.5M over the last 12 months
  • GoodInstitutional holders rose 7.1%, to 136 from 127 last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Industry
Orthopedic, prosthetic & surgical appliances & supplies (Health Care)
Employees
753
Website
inogen.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 11 Jan 2027 (an estimate: a year ago it reported on 12 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $77.2M, net loss $16.2M.
Quarter to 31 Dec 2021: revenue $76.4M, net income -$22.9MQuarter to 31 Dec 2021: revenue $76.4M, net income -$22.9MQuarter to 31 Mar 2022: revenue $80.4M, net income -$14.2MQuarter to 31 Mar 2022: revenue $80.4M, net income -$14.2MQuarter to 30 Jun 2022: revenue $103.4M, net income -$3.4MQuarter to 30 Jun 2022: revenue $103.4M, net income -$3.4MQuarter to 30 Sep 2022: revenue $105.4M, net income -$9.5MQuarter to 30 Sep 2022: revenue $105.4M, net income -$9.5MQuarter to 31 Dec 2022: revenue $88.1M, net income -$56.6MQuarter to 31 Dec 2022: revenue $88.1M, net income -$56.6MQuarter to 31 Mar 2023: revenue $72.2M, net income -$20.3MQuarter to 31 Mar 2023: revenue $72.2M, net income -$20.3MQuarter to 30 Jun 2023: revenue $83.6M, net income -$9.8MQuarter to 30 Jun 2023: revenue $83.6M, net income -$9.8MQuarter to 30 Sep 2023: revenue $84.0M, net income -$45.7MQuarter to 30 Sep 2023: revenue $84.0M, net income -$45.7MQuarter to 31 Dec 2023: revenue $75.9M, net income -$26.6MQuarter to 31 Dec 2023: revenue $75.9M, net income -$26.6MQuarter to 31 Mar 2024: revenue $78.0M, net income -$14.6MQuarter to 31 Mar 2024: revenue $78.0M, net income -$14.6MQuarter to 30 Jun 2024: revenue $88.8M, net income -$5.6MQuarter to 30 Jun 2024: revenue $88.8M, net income -$5.6MQuarter to 30 Sep 2024: revenue $88.8M, net income -$6.0MQuarter to 30 Sep 2024: revenue $88.8M, net income -$6.0MQuarter to 31 Dec 2024: revenue $80.1M, net income -$9.8MQuarter to 31 Dec 2024: revenue $80.1M, net income -$9.8MQuarter to 31 Mar 2025: revenue $82.3M, net income -$6.2MQuarter to 31 Mar 2025: revenue $82.3M, net income -$6.2MQuarter to 30 Jun 2025: revenue $92.3M, net income -$4.2MQuarter to 30 Jun 2025: revenue $92.3M, net income -$4.2MQuarter to 30 Sep 2025: revenue $92.4M, net income -$5.3MQuarter to 30 Sep 2025: revenue $92.4M, net income -$5.3MQuarter to 31 Dec 2025: revenue $81.7M, net income -$7.1MQuarter to 31 Dec 2025: revenue $81.7M, net income -$7.1MQuarter to 31 Mar 2026: revenue $85.1M, net income -$8.3MQuarter to 31 Mar 2026: revenue $85.1M, net income -$8.3MQuarter to 30 Jun 2026: revenue $95.1M, net income -$3.9MQuarter to 30 Jun 2026: revenue $95.1M, net income -$3.9MQuarter to 30 Sep 2026: revenue $77.2M, net income -$16.2MQuarter to 30 Sep 2026: revenue $77.2M, net income -$16.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $105.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$77.2M-$16.2M
30 Jun 2026$95.1M-$3.9M
31 Mar 2026$85.1M-$8.3M
31 Dec 2025$81.7M-$7.1M
30 Sep 2025$92.4M-$5.3M
30 Jun 2025$92.3M-$4.2M
31 Mar 2025$82.3M-$6.2M
31 Dec 2024$80.1M-$9.8M
30 Sep 2024$88.8M-$6.0M
30 Jun 2024$88.8M-$5.6M
31 Mar 2024$78.0M-$14.6M
31 Dec 2023$75.9M-$26.6M
30 Sep 2023$84.0M-$45.7M
30 Jun 2023$83.6M-$9.8M
31 Mar 2023$72.2M-$20.3M
31 Dec 2022$88.1M-$56.6M
30 Sep 2022$105.4M-$9.5M
30 Jun 2022$103.4M-$3.4M
31 Mar 2022$80.4M-$14.2M
31 Dec 2021$76.4M-$22.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $339.1M $333.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +1.6% +8.1%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$35.5M -$25.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.32 -$1.01
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 44.3% 45.0% 61.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -11.6% -9.2% 5.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -10.5% -7.6% -2.7%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -20.0% -20.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$11.3M -$15.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $96.8M $123.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$96.8M (net cash) -$123.2M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.22
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $6.04
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 27.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.41 2.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.12 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.88 3.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
InogenINGN (this company) $137.8Mloss0.41+1.6%-10.5%
Lakeland IndustriesLAKE $82.3Mloss0.43-0.4%-14.0%
Sanara MedTechSMTI $298.9Mloss2.7+9.8%-2.7%
Alpha Pro TechAPT $61.2M11.90.96+7.8%8.1%
NutribandNTRB $59.8Mloss37.0-37%-430%
Envoy MedicalCOCH $51.9Mloss225+11%–

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-16%

$77.2M vs $92.4M (quarter ended 30 Sep 2026)

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+7.1%

136 13F filers vs 127

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

70%

18.2M shares held by 13F filers (30 Sep 2026) of 26.0M outstanding (29 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.4%

1.4M shares sold short (30 Oct 2026) of 26.0M outstanding (29 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.8

1.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-8.3%

1.5M shares sold short in the report before, 1.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

39%

39% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$23K

the 12 months before: $0

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

6 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $5.30 on 20 Nov 2026, -20% over 12 months (12-month range $5.09 to $7.35)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $143K in the last 12 months (the 12 months before: $125K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 10 published in the last 12 months, +43% on the 12 months before.
Revenue per quarter. Revenue $77.2M in the latest quarter, -16% on a year earlier.
Capital spending per quarter. Capital spending $280K in the latest quarter, -51% on a year earlier.
Institutional holders (13F filers). 136 13F filers reported holding it in the latest 13F quarter, +12% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
19 Nov 20268-K and other filingsKevin R.M. Smith resigned as director, effective Nov 16, 2026; his officer and employee role ended Oct 30, 2026 under a separation agreement
5 Nov 20268-K and other filingsCompleted an acquisition or asset sale
5 Nov 20268-K and other filingsDirector or officer change
5 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Jul 20268-K and other filingsDirector or officer change
11 Jun 20268-K and other filingsDirector or officer change
6 Apr 20268-K and other filingsDirector or officer change
30 Mar 20268-K and other filingsDirector or officer change
30 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Jul 20258-K and other filingsDirector or officer change
19 May 20258-K and other filingsDirector or officer change
19 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Feb 20258-K and other filingsDirector or officer change
3 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Jul 20248-K and other filingsDirector or officer change
3 Jul 20248-K and other filingsDirector or officer change
7 Jun 20248-K and other filingsDirector or officer change
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 25 vs usual 14.50 (2024-03-31); 1.1x the same period a year earlier
15 May 20248-K and other filingsDirector or officer change
15 Apr 20248-K and other filingsDirector or officer change
24 Jan 20248-K and other filingsDirector or officer change
5 Jan 20248-K and other filingsDirector or officer change
27 Nov 20238-K and other filingsDirector or officer change
13 Nov 20238-K and other filingsDirector or officer change
18 Sep 20238-K and other filingsCompleted an acquisition or asset sale
7 Sep 20238-K and other filingsDirector or officer change
11 Aug 20238-K and other filingsDirector or officer change
31 Jul 20238-K and other filingsDirector or officer change
5 Jun 20238-K and other filingsDirector or officer change
22 Mar 20238-K and other filingsDirector or officer change
10 Feb 20238-K and other filingsDirector or officer change
10 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Dec 20228-K and other filingsRestructuring costs announced
29 Mar 2022Sharp changeShort interest spike: short interest spike, 878K vs usual 556K (2022-03-15); 1.6x the same period a year earlier
23 Mar 20228-K and other filingsDirector or officer change
4 Mar 20228-K and other filingsDirector or officer change
22 Feb 20228-K and other filingsDirector or officer change
28 Jan 20228-K and other filingsDirector or officer change
30 Dec 20218-K and other filingsDirector or officer change
13 Dec 20218-K and other filingsDirector or officer change
13 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$157K published
Month from 1 Sep 2022: -$77K published
Month from 1 May 2024: -$86K published
Month from 1 Mar 2025: $125K published
Month from 1 Jun 2026: -$70K published
Month from 1 Jul 2026: -$72K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Apr 2022: 2 published
Quarter from 1 Jul 2022: 3 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Jan 2024: 3 published
Quarter from 1 Apr 2024: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Oct 2024: 3 published
Quarter from 1 Jan 2025: 1 published
Quarter from 1 Apr 2025: 2 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Oct 2025: 1 published
Quarter from 1 Jan 2026: 2 published
Quarter from 1 Apr 2026: 1 published
Quarter from 1 Jul 2026: 5 published
Quarter from 1 Oct 2026: 2 published
Revenue per quarter
Quarter ended 31 Dec 2021: $76.4M, +3.3% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $80.4M, -7.5% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $103.4M, +1.8% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $105.4M, +13% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $88.1M, +15% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $72.2M, -10% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $83.6M, -19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $84.0M, -20% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $75.9M, -14% on a year earlier; public on 2 Mar 2024
Quarter ended 31 Mar 2024: $78.0M, +8.1% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $88.8M, +6.1% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $88.8M, +5.8% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $80.1M, +5.5% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $82.3M, +5.5% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $92.3M, +4.0% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $92.4M, +4.0% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $81.7M, +2.0% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $85.1M, +3.4% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $95.1M, +3.0% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $77.2M, -16% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $675K, -35% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $1.4M, -9.9% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $870K, -58% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $534K, -56% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $567K, -16% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $1.1M, -21% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $2.0M, +134% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $708K, +33% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $1.4M, +146% on a year earlier; public on 2 Mar 2024
Quarter ended 31 Mar 2024: $1.3M, +22% on a year earlier; public on 9 May 2024
Quarter ended 30 Sep 2024: $1.7M, +136% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $329K, -76% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $292K, -78% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $684K; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $568K, -66% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $979K, +198% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $210K, -28% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $711K, +3.9% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $280K, -51% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 152; public on 14 Feb 2022
31 Mar 2022 report: 141; public on 16 May 2022
30 Jun 2022 report: 127; public on 15 Aug 2022
30 Sep 2022 report: 127; public on 14 Nov 2022
31 Dec 2022 report: 124; public on 14 Feb 2023
31 Mar 2023 report: 142; public on 15 May 2023
30 Jun 2023 report: 129; public on 14 Aug 2023
30 Sep 2023 report: 118; public on 14 Nov 2023
31 Dec 2023 report: 119; public on 14 Feb 2024
31 Mar 2024 report: 124; public on 15 May 2024
30 Jun 2024 report: 121; public on 14 Aug 2024
30 Sep 2024 report: 126; public on 14 Nov 2024
31 Dec 2024 report: 130; public on 14 Feb 2025
31 Mar 2025 report: 123; public on 15 May 2025
30 Jun 2025 report: 121; public on 14 Aug 2025
30 Sep 2025 report: 121; public on 14 Nov 2025
31 Dec 2025 report: 126; public on 17 Feb 2026
31 Mar 2026 report: 122; public on 15 May 2026
30 Jun 2026 report: 127; public on 14 Aug 2026
30 Sep 2026 report: 136; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $12K published
Month from 1 Feb 2022: -$12K published
Month from 1 Sep 2025: $23K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is revenue, quarter at $77.2M (30 Sep 2026), 11% below its normal quarter of $87.0M; higher than 49% of its own history.
  • Insider net buying (open market): Insiders sold a net $143K in the last 12 months (the 12 months before: $125K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 10 published in the last 12 months, +43% on the 12 months before.
  • Revenue per quarter: Revenue $77.2M in the latest quarter, -16% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 6 Jul 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
6 Jul 2026Boyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR OffSellplanned in advance (10b5-1)10,938$6.60$72KForm 4
2 Jun 2026Boyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR OffSellplanned in advance (10b5-1)10,770$6.53$70KForm 4
4 Mar 2025Kevin Raymond Merrill SmithCEO and PresidentBuyplanned in advance (10b5-1)11,709$8.56$100KForm 4
4 Mar 2025Michael J. BourqueEVP, CFO & TreasurerBuyplanned in advance (10b5-1)3,000$8.32$25KForm 4
14 May 2024Jason SomerEVP, Gen. Counsel & SecretarySell10,000$8.56$86KForm 4
6 Sep 2022Jason SomerEVP, Gen. Counsel & SecretarySellafter exercising options1,145$28.16$32KForm 4
6 Sep 2022Stanislav GlezerEVP, Chief Technology OfficerSellafter exercising options1,576$28.16$44KForm 4
7 Mar 2022Ray Benjamin M AndersonDirectorSell4,516$34.68$157KForm 4

136 institutions reported shares at the end of Q3 2026, 70% of the shares outstanding; 19 opened a position, 11 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.1.7M6.71%$9.2M-4,204-0.2%
Armistice Capital, LLC1.2M4.75%$6.5M+140K+13%
Acadian Asset Management LLC1.1M4.22%No change
Vanguard Capital Management LLC1.0M3.99%$5.5MNo change
DAFNA Capital Management LLC845K3.25%$4.5MNo change
Arrowstreet Capital, Limited Partnership778K2.99%$4.1M+35K+4.7%
Morgan Stanley692K2.66%$3.6M+45K+7.0%
JPMorgan Chase & Co680K2.61%$3.7M+200K+42%
AQR Capital Management LLC655K2.52%$3.4M-283K-30%
State Street Corp592K2.28%$3.1M-359-0.1%

Company events

All 55 company events

In 12 months: 6 director or officer changes, 2 major agreements, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
19 Nov 2026Kevin R.M. Smith resigned as director, effective Nov 16, 2026; his officer and employee role ended Oct 30, 2026 under a separation agreement8-K
5 Nov 2026Director or officer change; Completed an acquisition or asset sale8-K
30 Sep 2026Signed a major agreement8-K
1 Jul 2026Director or officer change8-K
11 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
6 Apr 2026Director or officer change; Signed a major agreement8-K
30 Mar 2026Director or officer change8-K
29 Jul 2025Director or officer change8-K

The 5 newest of 58 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

15 Jan 2019confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Inogen (INGN): saw 57 13F filers open a new position in the quarter ended 31 Dec 2018, 2.1× the same quarter last year, while it had 4.0M shares sold short in the 15 Mar 2019 report, 5.0× the same report last year. Two unrelated kinds of activity within 105 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2018
  • Short interest and volume: Short interest spike, became public on 11 Jan 2019
  • Short interest and volume: Short interest spike, became public on 26 Jan 2019
  • Short interest and volume: Short interest spike, became public on 12 Feb 2019
  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2019
  • Short interest and volume: Short interest spike, became public on 28 Feb 2019
  • Short interest and volume: Short interest spike, became public on 12 Mar 2019
  • Short interest and volume: Short interest spike, became public on 27 Mar 2019
  • Short interest and volume: Short interest spike, became public on 10 Apr 2019
2016-12-31: 252017-03-31: 312017-06-30: 202017-09-30: 222017-12-31: 272018-03-31: 252018-06-30: 272018-09-30: 632018-12-31: 57
The quarter ended 31 Dec 2018 against the 8 quarters before it. this quarterearliernormal: 26
See the evidence (9 changes)

Institutional holdings: Many funds opening a new position became public on 14 Nov 2018

Inogen saw 63 13F filers open a new position in the quarter ended 30 Sep 2018, 2.9× the same quarter last year.

This period
63 (the quarter ended 30 Sep 2018)
Normal quarter (median of 8 earlier)
25
Typical spread (median absolute deviation)
2.5
How far from its usual level
+10.3
Same quarter last year
22
History used
1,644 days
2016-09-30: 202016-12-31: 252017-03-31: 312017-06-30: 202017-09-30: 222017-12-31: 272018-03-31: 252018-06-30: 272018-09-30: 63
the quarter ended 30 Sep 20188 earlier quartersnormal: 25

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 11 Jan 2019

Inogen had 2.8M shares sold short in the 31 Dec 2018 report, 3.3× the same report last year.

This period
2.8M (the 31 Dec 2018 report)
Normal report (median of 20 earlier)
872K
Typical spread (median absolute deviation)
84K
How far from its usual level
+15.8
Same report last year
850K
History used
367 days
2017-12-29: 850K2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M
the 31 Dec 2018 report20 earlier reportsnormal: 872K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jan 2019

Inogen had 3.0M shares sold short in the 15 Jan 2019 report, 3.8× the same report last year.

This period
3.0M (the 15 Jan 2019 report)
Normal report (median of 21 earlier)
895K
Typical spread (median absolute deviation)
102K
How far from its usual level
+14.0
Same report last year
793K
History used
382 days
2017-12-29: 850K2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M
the 15 Jan 2019 report21 earlier reportsnormal: 895K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Feb 2019

Inogen had 3.2M shares sold short in the 31 Jan 2019 report, 3.9× the same report last year.

This period
3.2M (the 31 Jan 2019 report)
Normal report (median of 22 earlier)
921K
Typical spread (median absolute deviation)
142K
How far from its usual level
+11.0
Same report last year
840K
History used
398 days
2017-12-29: 850K2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M2019-01-31: 3.2M
the 31 Jan 2019 report22 earlier reportsnormal: 921K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Feb 2019

Inogen saw 57 13F filers open a new position in the quarter ended 31 Dec 2018, 2.1× the same quarter last year.

This period
57 (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
26
Typical spread (median absolute deviation)
2.5
How far from its usual level
+8.4
Same quarter last year
27
History used
1,736 days
2016-12-31: 252017-03-31: 312017-06-30: 202017-09-30: 222017-12-31: 272018-03-31: 252018-06-30: 272018-09-30: 632018-12-31: 57
the quarter ended 31 Dec 20188 earlier quartersnormal: 26

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 28 Feb 2019

Inogen had 4.1M shares sold short in the 15 Feb 2019 report, 5.7× the same report last year.

This period
4.1M (the 15 Feb 2019 report)
Normal report (median of 23 earlier)
947K
Typical spread (median absolute deviation)
160K
How far from its usual level
+13.4
Same report last year
730K
History used
413 days
2017-12-29: 850K2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M2019-01-31: 3.2M2019-02-15: 4.1M
the 15 Feb 2019 report23 earlier reportsnormal: 947K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Mar 2019

Inogen had 3.9M shares sold short in the 28 Feb 2019 report, 5.5× the same report last year.

This period
3.9M (the 28 Feb 2019 report)
Normal report (median of 24 earlier)
947K
Typical spread (median absolute deviation)
171K
How far from its usual level
+11.8
Same report last year
715K
History used
426 days
2017-12-29: 850K2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M2019-01-31: 3.2M2019-02-15: 4.1M2019-02-28: 3.9M
the 28 Feb 2019 report24 earlier reportsnormal: 947K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Mar 2019

Inogen had 4.0M shares sold short in the 15 Mar 2019 report, 5.0× the same report last year.

This period
4.0M (the 15 Mar 2019 report)
Normal report (median of 24 earlier)
954K
Typical spread (median absolute deviation)
207K
How far from its usual level
+10.0
Same report last year
814K
History used
441 days
2018-01-12: 793K2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M2019-01-31: 3.2M2019-02-15: 4.1M2019-02-28: 3.9M2019-03-15: 4.0M
the 15 Mar 2019 report24 earlier reportsnormal: 954K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Apr 2019

Inogen had 4.1M shares sold short in the 29 Mar 2019 report, 5.0× the same report last year.

This period
4.1M (the 29 Mar 2019 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
311K
How far from its usual level
+6.6
Same report last year
814K
History used
455 days
2018-01-31: 840K2018-02-15: 730K2018-02-28: 715K2018-03-15: 814K2018-05-15: 765K2018-06-15: 895K2018-06-29: 803K2018-07-13: 836K2018-07-31: 813K2018-08-15: 947K2018-08-31: 961K2018-09-14: 947K2018-09-28: 1.1M2018-10-15: 1.6M2018-10-31: 1.8M2018-11-15: 2.8M2018-11-30: 2.6M2018-12-14: 2.8M2018-12-31: 2.8M2019-01-15: 3.0M2019-01-31: 3.2M2019-02-15: 4.1M2019-02-28: 3.9M2019-03-15: 4.0M2019-03-29: 4.1M
the 29 Mar 2019 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 19 Nov 2026Filings record

    Kevin R.M. Smith resigned as director, effective Nov 16, 2026; his officer and employee role ended Oct 30, 2026 under a separation agreement

  2. 5 Nov 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 5 Nov 2026Filings record

    Director or officer change

  4. 5 Nov 2026Filings record

    Completed an acquisition or asset sale

  5. 1 Jul 2026Filings record

    Director or officer change

  6. 11 Jun 2026Filings record

    Director or officer change

  7. 6 Apr 2026Filings record

    Director or officer change

  8. 30 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 30 Mar 2026Filings record

    Director or officer change

  10. 29 Jul 2025Filings record

    Director or officer change

  11. 19 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 19 May 2025Filings record

    Director or officer change

  13. 5 Mar 2025Insiders record

    Smith Kevin Raymond Merrill (CEO and President) bought 11,709 shares of INGN ($100,229) (dated 4 Mar 2025)

  14. 5 Mar 2025Insiders record

    Bourque Michael J. (EVP, CFO & Treasurer) bought 3,000 shares of INGN ($24,960) (dated 4 Mar 2025)

  15. 3 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 3 Feb 2025Filings record

    Director or officer change

  17. 31 Jul 2024Filings record

    Director or officer change

  18. 3 Jul 2024Filings record

    Director or officer change

  19. 7 Jun 2024Filings record

    Director or officer change

  20. 15 May 2024Institutional holdings change

    saw 25 13F filers open a new position in the quarter ended 31 Mar 2024, 1.1× the same quarter last year.

    Same quarter last year: 22; its normal quarter is 14.5.

    See the evidence
    This period
    25 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    14.5
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +3.5
    Same quarter last year
    22
    History used
    3,653 days
    2022-03-31: 132022-06-30: 162022-09-30: 142022-12-31: 122023-03-31: 222023-06-30: 212023-09-30: 132023-12-31: 152024-03-31: 25
    the quarter ended 31 Mar 20248 earlier quartersnormal: 14.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  21. 15 May 2024Filings record

    Director or officer change

  22. 15 Apr 2024Filings record

    Director or officer change

  23. 24 Jan 2024Filings record

    Director or officer change

  24. 5 Jan 2024Filings record

    Director or officer change

  25. 27 Nov 2023Filings record

    Director or officer change

  26. 13 Nov 2023Filings record

    Director or officer change

  27. 18 Sep 2023Filings record

    Completed an acquisition or asset sale

  28. 7 Sep 2023Filings record

    Director or officer change

  29. 11 Aug 2023Filings record

    Director or officer change

  30. 31 Jul 2023Filings record

    Director or officer change

  31. 5 Jun 2023Filings record

    Director or officer change

  32. 22 Mar 2023Filings record

    Director or officer change

  33. 10 Feb 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 10 Feb 2023Filings record

    Director or officer change

  35. 22 Dec 2022Filings record

    Restructuring costs announced

  36. 25 Mar 2022Short interest and volume change

    had 878K shares sold short in the 15 Mar 2022 report, 1.6× the same report last year.

    Same report last year: 559K; its normal report is 556K.

    See the evidence
    This period
    878K (the 15 Mar 2022 report)
    Normal report (median of 24 earlier)
    556K
    Typical spread (median absolute deviation)
    53K
    How far from its usual level
    +4.1
    Same report last year
    559K
    History used
    1,537 days
    2021-02-26: 826K2021-03-15: 559K2021-03-31: 543K2021-04-15: 554K2021-04-30: 482K2021-05-14: 576K2021-05-28: 544K2021-06-15: 496K2021-06-30: 393K2021-07-15: 379K2021-07-30: 428K2021-08-13: 611K2021-08-31: 559K2021-09-15: 485K2021-09-30: 668K2021-10-15: 607K2021-10-29: 615K2021-11-15: 560K2021-11-30: 505K2021-12-15: 550K2022-01-14: 540K2022-01-31: 604K2022-02-15: 701K2022-02-28: 730K2022-03-15: 878K
    the 15 Mar 2022 report24 earlier reportsnormal: 556K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 23 Mar 2022Filings record

    Director or officer change

  38. 4 Mar 2022Filings record

    Director or officer change

  39. 22 Feb 2022Filings record

    Director or officer change

  40. 28 Jan 2022Filings record

    Director or officer change

Showing the newest 40 of 70 entries; narrow the window or the kind of data to see older ones.

Not listed: 271 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001294133
Ticker
INGN
Domain
inogen.com
Employer name
INOGEN (1 unverified)
Hq location
MA|BEVERLY|01915 (1 unverified)
Name
Inogen Europe, B.V, Inogen Inc, Physio Assist SAS
Uei
LYCHKW41FL14
  • DOL H-1B labor condition applications and PERM certifications178 data points1 Oct 2019 to 6 Jul 2026
  • SEC Form 13F institutional holdings459 data points31 Mar 2014 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)158 records13 Jan 2016 to 19 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1061 data points31 Dec 2009 to 29 Oct 2026
  • SEC Form 4 insider transactions163 records, 516 data points19 Jan 2016 to 6 Jul 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards111 data points27 Sep 2011 to 3 Sep 2025